Sono Tek
Sono Tek's revenue rose 2.0% to $21 million in fiscal 2026. Its operating margin was 8.7%, up from 4.9% a year earlier. Free cash flow was $3 million, up 5273.5%. The diluted share count fell 0.2%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Income statement
From fiscal 2017 to 2026, earnings per share grew 30.5% a year and net income 37.9% a year, as new shares raised the share count by 5% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | 11 | 11 | 12 | 12 | 15 |
| Debt incl. finance leases | — | — | — | — | — |
| Net debt (negative means net cash) | — | — | — | — | — |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | — | — | — | — | — |
| Interest coverage | — | — | — | — | — |
| Current ratio | 3.9x | 3.0x | 2.8x | 3.5x | 3.5x |
| Quick ratio | 3.3x | 2.4x | 2.0x | 2.6x | 2.9x |
Cash flow
Projections
Project Sono Tek's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 1 insider bought $9,888 of Sono Tek shares on the open market, and 2 insiders sold $159,126.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Stephen James BagleyCFO | Sold | 8,346 | $5.13 | $42,815 | Form 4 |
| Jul 27, 2026 | Stephen James BagleyCFO | Sold | 1,200 | $5.08 | $6,096 | Form 4 |
| Jul 23, 2026 | Stephen James BagleyCFO | Sold | 3,454 | $5.43 | $18,755 | Form 4 |
| Jul 21, 2026 | Christopher L CoccioDirector | Sold | 17,000 | $5.38 | $91,460 | Form 4 |
| Mar 5, 2026 | Adeniyi LawalDirector | Bought | 2,400 | $4.12 | $9,888 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY24 | FY25 | FY26 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | 32.7% | 4.4% | 16.4% |
| Altman Z'' | 7.17 | 8.46 | 8.78 |
| Accruals ratio | 1.3% | 3.2% | −5.8% |
The nine F-score tests
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Fail | Pass |
| Cash from operations exceeds net income | Fail | Fail | Pass |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | Fail | Pass | Pass |
| Share count didn't rise | Fail | Pass | Pass |
| Gross margin rose | Fail | Fail | Pass |
| Revenue rose relative to assets | Pass | Fail | Pass |
| F-score | — | — | — |
Compare
Put Sono Tek side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Sono Tek | FY26 | 2.0% | 8.7% | 14.4% | — | — | — | |
| Data I/O | FY25 | −1.2% | −23.8% | −12.9% | — | — | — | Compare |
| CVD Equipment | FY25 | −4.1% | −7.4% | −14.4% | — | — | — | Compare |
| Aehr Test Systems | FY26 | −15.2% | −28.3% | −10.8% | −11.1% | — | 2 | Compare |
| Trio-Tech International | FY26 | 71.7% | −0.3% | 2.7% | −0.5% | −10.2x | 5 | Compare |
10 years of figures
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 10 | 11 | 12 | 15 | 15 | 17 | 15 | 20 | 20 | 21 |
| Revenue growth | −18.6% | 14.3% | 5.5% | 32.3% | −3.4% | 15.5% | −12.1% | 30.8% | 4.1% | 2.0% |
| Gross profit | 4 | 5 | 5 | 7 | 7 | 9 | 8 | 10 | 10 | 11 |
| Research and development | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 |
| Operating income | −0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 2 |
| Net income | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 2 |
| Diluted EPS (US$) | 0.01 | 0.02 | 0.01 | 0.07 | 0.07 | 0.16 | 0.04 | 0.09 | 0.08 | 0.11 |
| Diluted shares (millions) | 15 | 15 | 15 | 15 | 16 | 16 | 16 | 16 | 16 | 16 |
| Cash flow | ||||||||||
| Cash from operations | 1 | 2 | −0 | 3 | 1 | 2 | 1 | 1 | 0 | 3 |
| Capital expenditure | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 |
| Free cash flow | 1 | 2 | −1 | 3 | 0 | 2 | 1 | 0 | 0 | 3 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 5 | 6 | 6 | 8 | 9 | 11 | 11 | 12 | 12 | 15 |
| Debt incl. finance leases | 1 | 1 | 1 | 1 | 1 | — | — | — | — | — |
| Total assets | 11 | 12 | 12 | 15 | 16 | 18 | 20 | 23 | 23 | 26 |
| Total liabilities | 3 | 3 | 4 | 5 | 6 | 4 | 6 | 7 | 6 | 7 |
| Shareholders' equity | 8 | 8 | 9 | 10 | 11 | 14 | 15 | 16 | 18 | 20 |
| Margins and ratios | ||||||||||
| Gross margin | 45.3% | 48.1% | 45.2% | 47.6% | 47.2% | 50.3% | 50.8% | 50.0% | 47.5% | 50.5% |
| Operating margin | −1.9% | 3.5% | 0.7% | 7.3% | 9.0% | 11.0% | 4.5% | 6.0% | 4.9% | 8.7% |
| Net margin | 1.0% | 3.3% | 1.4% | 7.2% | 7.6% | 14.8% | 4.2% | 7.3% | 6.2% | 8.6% |
| Free cash flow margin | 8.8% | 14.7% | −5.7% | 16.5% | 2.6% | 11.6% | 5.1% | 1.9% | 0.3% | 14.4% |
| Rule of 40 (growth + FCF margin) | −9.8% | 28.9% | −0.2% | 48.8% | −0.8% | 27.1% | −7.0% | 32.7% | 4.4% | 16.4% |
| Return on capital | −3.9% | 8.5% | 2.1% | 31.1% | 37.7% | — | — | — | — | — |
| Return on equity | 1.2% | 4.5% | 1.9% | 12.1% | 10.8% | 20.6% | 4.5% | 9.3% | 7.5% | 9.6% |
| Return on assets | 0.9% | 3.3% | 1.4% | 8.2% | 7.2% | 14.9% | 3.4% | 6.7% | 5.5% | 7.2% |
| Net debt to EBITDA | −14.2x | −6.9x | −11.2x | −4.7x | −4.2x | — | — | — | — | — |